PRECIPITIN in gel and radioimmunoassays for CEA were first tested by Gold and his collaborators for the serodiagnosis of cancer arising in the gut, stomach and pancreas (Gold and Freedman, 1965; Thompson et al., 1969) . Extensive trials with modified CEA radioimmunoassays have indicated that these tests recognize tumour associated CEA reacting antigens present in tumours of other origins (LoGerfo, Krupey and Hansen, 1971; Moore et al., 1971; Reynoso et al., 1972; Laurence et al., 1972) as well as in serum from patients with alcoholic liver disease, ulcerative colitis and Crohn's disease (LoGerfo et al., 1971; Moore et al., 1971; Moore, Kantrowitz and Zamcheck, 1972) .
While use of the current CEA radioimmunoassay is accepted by some, its broad spectrum reactivity lacks the sensitivity necessary to detect early cancer cases, or to pinpoint the tissue origin of the CEA reacting molecules (Snyder and Miller, 1973) . To overcome this defect " CEA fingerprints ' were obtained by electrofocusing salirnw extracts from tumours and norinal tissues and performing CEA radioimmunoassays on each fraction. Profiles from all sources were then compared to determine which peaks could be designated as normal, neonatal or oncofoetal antigens capable of reacting with broad spectrum CEA antisera.
MATERIALS AND METHODS
Freshly obtained specimens were homogenized in saline (2: 1 w/v) at 4°C and in the presence of 50 pul normal goat serum in 5 ml distilled water and then dialysed extensively against distilled water for 24-36 hours. Controls were treated in the same fashion.
RESULTS
Earlier experiments have established the necessity for extensive urea pretreatment of saline extracts of tissue for optimal dissociation and release of glycoprotein molecules (Goleski, Janowitz and Rule, 1972) . Electrofocusing profiles of protein, pH and CEA radioimmunoassays form exquisitely sensitive fingerprints from essentially crude extracts. All peaks greater than 50 ng CEA/tube were considered to contain significant amounts of CEA activity. carcinomata of the colon. Seven major peaks are found, with 6 minor peaks (or major peak subcomponents). These can be compared with Fig. 2 Fig. 3 contains approximately 6 peaks. CEA reactivity is most noticeably lacking at pH 3. Fig. 4 shows the CEA fingerprint of the perchloric acid (PCA) extract of the pool of colon carcinomata initially shown in Fig. 1 CEA fingerprints. The multiplicity of peaks obtained with saline extracts of pooled primary colonic cancers helps to explain in part the inability of the present test to identify circulating oncofoetal antigens of colon origin (Snyder and Miller, 1973) . The use of CEA fingerprints to differentiate excessive production of normal colon antigens, as opposed to those of neoplastic origin, remains a possibility with certain refinements to this technique.
Likewise, the production of more specific antisera and antigens should certainly be attempted, in order to redesign the current CEA radioimmunoassay. Such immunochemical engineering would perhaps eliminate both the false positives and false negatives at present inherent in the test and thus provide a test of great potential diagnostic value.
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